NeuroBo Pharmaceuticals, Inc. (NRBO) earnings
Quarterly and annual NRBO reports and results, each read against the price at its own news timestamp. Back to the NRBO overview →
11 measured NRBO earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q MetaVia Inc. For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K MetaVia Inc. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q NeuroBo Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +1.85% | +3.70% | |
| NeuroBo Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.00% | +4.28% | |
| Form 10-Q NeuroBo Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +3.98% | +3.45% | |
| NeuroBo Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | +3.27% | +6.27% | |
| Form 10-Q NeuroBo Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.96% | |
| NeuroBo Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.00% | +2.96% | |
| Form 10-K NeuroBo Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +5.10% | -1.46% | |
| Form 10-Q NeuroBo Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -4.42% | -4.33% | |
| NeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | -4.42% | -4.33% |
Keep exploring
More NRBO: analyst actions → · SEC filings → · NRBO overview →